DNA demethylating therapy reverts mesenchymal stromal cells derived from high risk myelodysplastic patients to a normal phenotype-Reference-Cited by-同舟云学术

DNA demethylating therapy reverts mesenchymal stromal cells derived from high risk myelodysplastic patients to a normal phenotype

Published:2016-04-22 Issue:5 Volume:177 Page:818-822
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Maurizi Giulia¹,Mattiucci Domenico¹,Mariani Marianna¹,Ciarlantini Marco¹,Traini Sabrina¹,Mancini Stefania¹,Olivieri Attilio¹,Leoni Pietro¹,Poloni Antonella¹

Affiliation:

1. Clinica di Ematologia; Dipartimento di Scienze Cliniche e Molecolari; Università Politecnica delle Marche; Ancona Italy

Funder

Associazione Italiana Contro le Leucemie - Linfomi e Mieloma

sezione di Ancona-ONLUS

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjh.14115/fullpdf

Reference9 articles.

1. MCP-1, not MIP-1alpha, is the endogenous chemokine that cooperates with TGF-beta to inhibit the cycling of primitive normal but not leukemic (CML) progenitors in long-term human marrow cultures;Cashman;Blood,1998

2. Myelodysplastic syndromes: the complexity of stem-cell diseases;Corey;Nature Reviews Cancer,2007

3. Notch signaling in the malignant bone marrow microenvironment: implications for a niche-based model of oncogenesis;Evans;Annals of the New York Academy of Sciences,2015

4. Insufficient stromal support in MDS results from molecular and functional deficits of mesenchymal stromal cells;Geyh;Leukemia,2013

5. Genealogy, expression, and cellular function of transforming growth factor-beta;Govinden;Pharmacolgy and Therapeutics,2003

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Engagement of Mesenchymal Stromal Cells in the Remodeling of the Bone Marrow Microenvironment in Hematological Cancers;Biomolecules;2023-11-24

2. In Vitro Insights Into the Influence of Marrow Mesodermal/Mesenchymal Progenitor Cells on Acute Myelogenous Leukemia and Myelodysplastic Syndromes;Stem Cells;2023-06-22

3. Genome-Wide Methylation Changes Associated with Replicative Senescence and Differentiation in Endothelial and Bone Marrow Mesenchymal Stromal Cells;Cells;2023-01-11

4. Impairment of FOXM1 expression in mesenchymal cells from patients with myeloid neoplasms, de novo and therapy-related, may compromise their ability to support hematopoiesis;Scientific Reports;2022-12-08

5. Aging of Bone Marrow Mesenchymal Stromal Cells: Hematopoiesis Disturbances and Potential Role in the Development of Hematologic Cancers;Cancers;2020-12-29